Press Coverage: Williams Companies Stockholder Litigation Trial Challenging Novel Anti-Shareholder Corporate Governance Provision

January 13, 2021

The BLB&G trial team of Mark Lebovitch, Gregory V. Varallo, and Thomas James challenged a novel anti-shareholder corporate governance provision in Delaware Chancery Court.

This closely-watched trial marks the first full-blown challenge to the most recent—and harmful—poison pill developments.

Press coverage of the case is highlighted in the links below, and can also be accessed in the PDFs. More information about the case can be accessed using the Related Case link on the left-hand sidebar.

PDFs of Article

The Deal: "Williams Pill Breaches Director Fiduciary Duty: Wolosky"

Law360: "Chancery Opens Trial on Williams' 'Nuclear' Takeover Defense"

Law360: "Williams Expert Says Poison Pill No Threat To Shareholders"

Links to Article

The Deal: "Williams Pill Breaches Director Fiduciary Duty: Wolosky"

Law360: "Chancery Opens Trial on Williams' 'Nuclear' Takeover Defense"

Law360: "Williams Expert Says Poison Pill No Threat To Shareholders"